G T Stevenson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G T Stevenson

Showing results (91-100 of 93) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 93 results.

Cell Biophysics|January 1, 1994

Mechanisms in removal of tumor by antibodyG T Stevenson, A J Bell, T R Evans, et al.

Blood|May 1, 1996

HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factorD Elsässer, T Valerius, R Repp, et al.

Human Gene Therapy|July 1, 1997

A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. CRC NO: 92/33. Protocol NO: PH1/027R E Hawkins, S J Russell, R Marcus, et al.

Pageof 10

Search research articles

Showing results (91-100 of 93) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 93 results.

Cell Biophysics|January 1, 1994

Mechanisms in removal of tumor by antibodyG T Stevenson, A J Bell, T R Evans, et al.

Blood|May 1, 1996

HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factorD Elsässer, T Valerius, R Repp, et al.

Human Gene Therapy|July 1, 1997

A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. CRC NO: 92/33. Protocol NO: PH1/027R E Hawkins, S J Russell, R Marcus, et al.

Pageof 10